Quest Diagnostics (DGX) Operating Income (2016 - 2025)
Quest Diagnostics (DGX) has disclosed Operating Income for 17 consecutive years, with $386.0 million as the latest value for Q4 2025.
- Quarterly Operating Income rose 6.93% to $386.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, up 15.6% year-over-year, with the annual reading at $1.6 billion for FY2025, 15.6% up from the prior year.
- Operating Income hit $386.0 million in Q4 2025 for Quest Diagnostics, roughly flat from $386.0 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $660.0 million in Q1 2021 to a low of $135.0 million in Q4 2022.
- Historically, Operating Income has averaged $398.6 million across 5 years, with a median of $373.5 million in 2024.
- Biggest five-year swings in Operating Income: surged 277.14% in 2021 and later crashed 74.81% in 2022.
- Year by year, Operating Income stood at $536.0 million in 2021, then plummeted by 74.81% to $135.0 million in 2022, then soared by 97.78% to $267.0 million in 2023, then surged by 35.21% to $361.0 million in 2024, then grew by 6.93% to $386.0 million in 2025.
- Business Quant data shows Operating Income for DGX at $386.0 million in Q4 2025, $386.0 million in Q3 2025, and $438.0 million in Q2 2025.